optical coherence tomography images Search Results


94
Carl Zeiss microscope axioplan 2
Microscope Axioplan 2, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/pm24687900-137-11-14?v=Carl+Zeiss
Average 94 stars, based on 1 article reviews
microscope axioplan 2 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Helmholtz Zentrum fur Infektionsforschung GmbH optical coherence tomography
Optical Coherence Tomography, supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/10__1667_slash_rade___20___00163__1-12-0-43?v=Helmholtz+Zentrum+fur+Infektionsforschung+GmbH
Average 90 stars, based on 1 article reviews
optical coherence tomography - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
heidelberg engineering optical coherence tomography scanner heidelberg engineering spectralisoct
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Optical Coherence Tomography Scanner Heidelberg Engineering Spectralisoct, supplied by heidelberg engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/bio_rxiv__2025__03__13__642537-205-8-12?v=heidelberg+engineering
Average 90 stars, based on 1 article reviews
optical coherence tomography scanner heidelberg engineering spectralisoct - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
heidelberg engineering optical coherence tomography (oct) (spectralis
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Optical Coherence Tomography (Oct) (Spectralis, supplied by heidelberg engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/ppr0443484-214-7-11?v=heidelberg+engineering
Average 90 stars, based on 1 article reviews
optical coherence tomography (oct) (spectralis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Humphrey Instruments Inc oct (oct3
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Oct (Oct3, supplied by Humphrey Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/pmc02893298-219-10-14?v=Humphrey+Instruments+Inc
Average 90 stars, based on 1 article reviews
oct (oct3 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Humphrey Instruments Inc stratus oct model 3000
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Stratus Oct Model 3000, supplied by Humphrey Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/pm18425062-19-18-25?v=Humphrey+Instruments+Inc
Average 90 stars, based on 1 article reviews
stratus oct model 3000 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
heidelberg engineering optic coherence tomography
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Optic Coherence Tomography, supplied by heidelberg engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/pmc05125341-58-5-18?v=heidelberg+engineering
Average 90 stars, based on 1 article reviews
optic coherence tomography - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
heidelberg engineering spectral-domain optical coherence tomography hra
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Spectral Domain Optical Coherence Tomography Hra, supplied by heidelberg engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/pm40208579-69-16-21?v=heidelberg+engineering
Average 90 stars, based on 1 article reviews
spectral-domain optical coherence tomography hra - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Selzer GmbH optical coherence tomography
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Optical Coherence Tomography, supplied by Selzer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/10__1161_slash_circulationaha__120__049661-46-22-12?v=Selzer+GmbH
Average 90 stars, based on 1 article reviews
optical coherence tomography - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
topcon corporation swept-source optical coherence tomography (oct
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Swept Source Optical Coherence Tomography (Oct, supplied by topcon corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/pmc11675463-27-9-16?v=topcon+corporation
Average 90 stars, based on 1 article reviews
swept-source optical coherence tomography (oct - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Verlag GmbH optical coherence tomography
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Optical Coherence Tomography, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/10__1364_slash_oe__22__021944-207-3-12?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
optical coherence tomography - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Imalux Corporation optical coherence tomography system niris
(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative <t>optical</t> <t>coherence</t> <t>tomography</t> (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).
Optical Coherence Tomography System Niris, supplied by Imalux Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optical+coherence+tomography+images/us08603080-119-30-35?v=Imalux+Corporation
Average 90 stars, based on 1 article reviews
optical coherence tomography system niris - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative optical coherence tomography (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).

Journal: bioRxiv

Article Title: Longitudinal analysis of retinal cell state transitions in RB1 -deficient retinal organoids reveals the nascent cone precursors are the earliest cell-origin of human retinoblastoma

doi: 10.1101/2025.03.13.642537

Figure Lengend Snippet: (A) Schematic outline of the generation of 1st and 2nd xenograft. (B) Representative optical coherence tomography (OCT) images of engrafted eyes at 10 WAI from RB1 −/− ROs. An obvious highly reflective tumor was observed. (C) Representative slit-lamp images of engrafted eyes at 13 WAI from RB1 −/− ROs. Whitish tumor cells were observed in anterior chambers. (D) Representative microscopic image of tumor mass derived from 1st xenograft. (E) Representative H&E staining images of 1st xenograft from RB1 −/− ROs. The dash lines indicate the rosette structure. (F) Representative H&E staining images of 2nd xenograft with injection of 1st tumor cells. No rosettes were observed. (G) Representative immunostaining for Ki67 and quantification of Ki67 + cells in 1st and 2nd xenograft. ** P < 0.01 vs. 1st xenograft, n = 3. (H) Representative immunostaining for human specific marker (STEM121), cone markers (RCVRN, RXRγ) and Rb markers (SYK, p16 INK4a ) in 1st and 2nd tumor. (I) Representative immunostaining for L/M opsin in 1st and 2nd tumor. Scale bars = 200 μm (D), 500 (left), 50 (right) μm (E, F) and 50 μm (G, H, I).

Article Snippet: Spectral domain optical coherence tomography (SD-OCT) with an optical coherence tomography scanner (Heidelberg Engineering, SpectralisOCT, Germany) and anterior chamber photography with a slit lamp digital imaging system (Topcon, SL-D7/DC-3/IMAGEnet, Japan) were used to track and monitor the grafts.

Techniques: Tomography, Derivative Assay, Staining, Injection, Immunostaining, Marker